What is the current stock price of Sensorion S.A. (ALSEN.PA)?

As of the latest market data, Sensorion S.A. (ALSEN.PA) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Sensorion S.A. (ALSEN.PA) pay a dividend?

Based on current data, Sensorion S.A. does not have a confirmed active dividend policy.

What is the market cap of Sensorion S.A.?

The current market capitalization of Sensorion S.A. (ALSEN.PA) is approximately unavailable.

ALSEN.PA

Sensorion S.A.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2015-04-21

Beta

0.37

Websitewww.sensorion.com↗